Correlation Between Iteos Therapeutics and Pmv Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Iteos Therapeutics and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iteos Therapeutics and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iteos Therapeutics and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Iteos Therapeutics and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iteos Therapeutics with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iteos Therapeutics and Pmv Pharmaceuticals.
Diversification Opportunities for Iteos Therapeutics and Pmv Pharmaceuticals
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Iteos and Pmv is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Iteos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iteos Therapeutics are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Iteos Therapeutics i.e., Iteos Therapeutics and Pmv Pharmaceuticals go up and down completely randomly.
Pair Corralation between Iteos Therapeutics and Pmv Pharmaceuticals
Given the investment horizon of 90 days Iteos Therapeutics is expected to under-perform the Pmv Pharmaceuticals. In addition to that, Iteos Therapeutics is 1.15 times more volatile than Pmv Pharmaceuticals. It trades about -0.12 of its total potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 143.00 in Pmv Pharmaceuticals on November 28, 2024 and sell it today you would lose (1.00) from holding Pmv Pharmaceuticals or give up 0.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iteos Therapeutics vs. Pmv Pharmaceuticals
Performance |
| Timeline |
| Iteos Therapeutics |
| Pmv Pharmaceuticals |
Iteos Therapeutics and Pmv Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iteos Therapeutics and Pmv Pharmaceuticals
The main advantage of trading using opposite Iteos Therapeutics and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iteos Therapeutics position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.| Iteos Therapeutics vs. Annexon | Iteos Therapeutics vs. Monte Rosa Therapeutics | Iteos Therapeutics vs. Design Therapeutics | Iteos Therapeutics vs. Erasca Inc |
| Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |